Treatment of Ménétrier's Disease with a Monoclonal Antibody against the Epidermal Growth Factor Receptor
J. Steven Burdick, M.D., EunKyung Chung, Ph.D., Gordon Tanner, M.D., Mei Sun, M.D., June E. Paciga, B.S., Jin Q. Cheng, M.D., Ph.D., Kay Washington, M.D., Ph.D., James R. Goldenring, M.D., Ph.D., and Robert J. Coffey, M.D.
Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.
MÉnÉtrier's disease (hypoproteinemic hypertrophicgastropathy) is a rare, acquired, premalignant disorder of thestomach.1,2,3,4 It is characterized by giant hypertrophic foldsthat most often involve the fundus, excess mucus secretion,decreased acid secretion (hypochlorhydria), and hypoproteinemiadue to selective loss of serum proteins across the gastric mucosa.5,6The cause of Ménétrier's disease is unknown, althoughinfection with cytomegalovirus (CMV) in children and infectionwith Helicobacter pylori have been implicated.7,8 Symptoms includeepigastric pain, vomiting, edema, anorexia, and weight loss.Gastric cancer has been reported at diagnosis or during follow-upin patients with hypertrophic gastropathy. Evidence of the benefitsof anticholinergic . . . [Full Text of this Article]
Case Report
Results
Discussion
Source Information
From the Departments of Medicine and Pathology, University of Texas Southwestern Medical Center, Dallas (J.S.B.); the Departments of Pathology, Medicine, and Cell Biology, Vanderbilt University School of Medicine and Nashville Veterans Affairs Medical Center, Nashville (E.C., G.T., K.W., R.J.C.); the Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa (M.S., J.E.P., J.Q.C.); and the Augusta Veterans Affairs Medical Center and Departments of Medicine, Surgery, and Cellular Biology and Anatomy, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta (J.R.G.).
Address reprint requests to Dr. Coffey at CC-2201 Medical Center North, Vanderbilt University, Nashville, TN 37232, or at coffeyrj@ctrvax.vanderbilt.edu.
References
This article has been cited by other articles:
Mutsaers, A. J., Francia, G., Man, S., Lee, C. R., Ebos, J. M.L., Wu, Y., Witte, L., Berry, S., Moore, M., Kerbel, R. S.
(2009). Dose-Dependent Increases in Circulating TGF-{alpha} and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent. Clin. Cancer Res.
15: 2397-2405
[Abstract][Full Text]
Friedman, J., Platnick, J., Farruggia, S., Khilko, N., Mody, K., Tyshkov, M.
(2009). Best Cases from the AFIP: Menetrier Disease. RadioGraphics
29: 297-301
[Full Text]
Rothenberg, M. L., LaFleur, B., Levy, D. E., Washington, M. K., Morgan-Meadows, S. L., Ramanathan, R. K., Berlin, J. D., Benson, A. B. III, Coffey, R. J.
(2005). Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal Adenocarcinoma. JCO
23: 9265-9274
[Abstract][Full Text]
Elinav, E, Korem, M, Ofran, Y, Migdal, A, Doviner, V, Hiler, N, Aamar, S, Bursztyn, M
(2004). Hyperplastic gastropathy as a presenting manifestation of systemic lupus erythematosus. Lupus
13: 60-63
[Abstract]
van den Brink, G R, Hardwick, J C H, Nielsen, C, Xu, C, ten Kate, F J, Glickman, J, van Deventer, S J H, Roberts, D J, Peppelenbosch, M P
(2003). Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Mol. Pathol.
56: 150-155
[Abstract][Full Text]
van den Brink, G R, Hardwick, J C H, Nielsen, C, Xu, C, ten Kate, F J, Glickman, J, van Deventer, S J H, Roberts, D J, Peppelenbosch, M P
(2002). Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Gut
51: 628-633
[Abstract][Full Text]